These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25936682)

  • 1. The contribution of neighbours to an individual's risk of typhoid outcome.
    Chao DL; Park JK; Marks F; Ochiai RL; Longini IM; Halloran ME
    Epidemiol Infect; 2015 Dec; 143(16):3520-7. PubMed ID: 25936682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the typhoid Vi vaccine in overseas travelers from England.
    Wagner KS; Freedman JL; Andrews NJ; Jones JA
    J Travel Med; 2015; 22(2):87-93. PubMed ID: 25444695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typhoid fever in children aged less than 5 years.
    Sinha A; Sazawal S; Kumar R; Sood S; Reddaiah VP; Singh B; Rao M; Naficy A; Clemens JD; Bhan MK
    Lancet; 1999 Aug; 354(9180):734-7. PubMed ID: 10475185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Typhoid fever in school children: by what measures is the modification of the clinical course due to oral vaccination?].
    Contreras R; Ferreccio C; Sotomayor V; Astroza L; Berríos G; Ortiz E; Palomino C; Prenzel I; Pinto ME; Levine M
    Rev Med Chil; 1992 Feb; 120(2):134-41. PubMed ID: 1340549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
    Yang HH; Wu CG; Xie GZ; Gu QW; Wang BR; Wang LY; Wang HF; Ding ZS; Yang Y; Tan WS; Wang WY; Wang XC; Qin M; Wang JH; Tang HA; Jiang XM; Li YH; Wang ML; Zhang SL; Li GL
    Bull World Health Organ; 2001; 79(7):625-31. PubMed ID: 11477965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
    Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state.
    Saul A; Smith T; Maire N
    PLoS One; 2013; 8(9):e74097. PubMed ID: 24040177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of typhoid fever transmission dynamic models and economic evaluations of vaccination.
    Watson CH; Edmunds WJ
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C42-54. PubMed ID: 25921288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI; Ochiai RL; Clemens JD
    Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled field trials of three different oral killed typhoid vaccines in India.
    Chuttani CS
    Dev Biol Stand; 1976; 33():98-101. PubMed ID: 782977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
    Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
    J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.
    Antillón M; Bilcke J; Paltiel AD; Pitzer VE
    Vaccine; 2017 Jun; 35(27):3506-3514. PubMed ID: 28527687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.